First Opinion Michael Banks Improving the FDA-EMA parallel scientific advice program to advance complex generics
First Opinion Steffie Woolhandler, David U. Himmelstein, Elizabeth Schrier, and Hope Schwartz Private equity: health care’s vampire
Letters to the editor Patrick Skerrett First Opinion readers on Noah Lyles and Covid-19, the dearth of geriatricians, PBMs, and more
First Opinion Sarah Emond STAT Plus: What the newly released Medicare prices for 10 drugs do and don’t tell us
First Opinion Peter Staley Gilead must be held accountable for the harm caused by ‘patent hopping’ an HIV treatment
First Opinion David Introcaso HHS says it is working to stop the climate crisis. But it’s really just climate washing
First Opinion Deborah M. Stein and Robert V. O'Toole Aspirin after a broken bone: health equity in a $5 bottle
First Opinion T. Joseph Mattingly II, David A. Hyman, and Ge Bai Some ‘inconvenient’ truths about pharmacy benefit managers
First Opinion Susannah Baruch Getting to ‘Plan B’ for psychedelic medicine: Lessons from reproductive health
First Opinion Giulia Balconi Controlling obesity is a noble goal. Controlling mpox is a far more urgent one
Letters to the editor Patrick Skerrett First Opinion readers respond to essays on right to try lies, pharma execs, and more
First Opinion Arthur L. Caplan Noah Lyles’ collapse with Covid: How not to manage health at the Olympics
First Opinion Anne N. Thorndike Small changes in food ‘choice environments’ in stores can make a healthy difference
First Opinion Evelyn Tenenbaum and Jed Adam Gross Removing barriers to split liver transplants will save lives
First Opinion Fred D. Ledley Give pharmaceutical execs the benefit of doubt — but they need to work for it
First Opinion Staja “Star” Booker When life mirrors research: What a fall on the ice taught me about being Black and in pain
First Opinion David Blumenthal and Sara Rosenbaum Congress is unprepared for the post-Chevron world. It needs help from subject matter experts
First Opinion Sanjay Basu Cost-effectiveness of health interventions may be perpetuating health disparities. Here’s how to fix that
First Opinion Jeffrey S. Flier Diversity statements should not be required for federal STEMM grant funding
First Opinion Jo Morrison and Eric Moore Performance-enhancing drugs or placebos? The myth at the heart of anti-doping